Search

Zesiewicz, TA, and RA Hauser. 2000. “Depression in Patients With Parkinson’s Disease: Epidemiology, Pathophysiology and Treatment Options. CNS Drugs 2000;13:227-304.”. CNS Drugs.

Zesiewicz, TA, M Helal, and RA Hauser. 2000. “Sildenafil Citrate (Viagra) for the Treatment of Erectile Dysfunction in Men With Parkinson’s Disease. Movement Disorders 2000;15:305-308.”. Movement Disorders.

Freeman, TB, F Cicchetti, RA Hauser, TW Deacon, and . 2000. “Transplanted Fetal Striatum in Huntington’s Disease: Phenotypic Development and Lack of Pathology. Proceedings of the National Academy of Sciences of the United States of America. 2000;97:13877-82.”. Proceedings of the National Academy of Sciences of the United States of America.

Freeman, TB, RA Hauser, PR Sanberg, and S Saporta. 2000. “Neural Transplantation for the Treatment of Huntington’s Disease. Progress in Brain Research 2000;127:405-411.”. Progress in Brain Research.

Adler, CH, C Singer, C O’Brien, RA Hauser, MF Lew, KL Marek, E Dorflinger, S Pedder, D Deptula, and K Yoo. 1998. “Randomized, Placebo-Controlled Study of Tolcapone in Patients With Fluctuating Parkinson Disease Treated With Levodopa-Carbidopa. Arch Neurol 1998;55:1089-1095.”. Arch Neurol.

Hauser, RA, CW Olanow, D Burdick, R Dhall, JA de Marcaida, RA Gil, DL Kreitzman, L Elmer, A McGarry, and K Kieburtz. 2024. “For the P2B Study Group. Double-Blind Study Comparing P2B001 (combination of Low-Doses of Extended-Release Pramipexole and Rasagiline) to Components and to Optimised Doses of Pramipexole-Extended Release in Early Parkinson’s Disease.”. . Mov Disord. 2024 Feb;39(2):350-359. Doi: 10.1002/Mds.29642. Epub 2023 Oct 27. PMID: 37886872.

Fung, VSC, J Aldred, MP Arroyo, F Bergquist, RA Hauser, M Bouchard, S Bray, et al. 2024. “Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion for the Treatment of Motor Fluctuations in Parkinson’s Disease: Considerations for Initiation and Maintenance.”. . Clin Park Relat Disord. 2024 Feb 10;10:100239. Doi: 10.1016/J.prdoa.2024.100239. ECollection 2024. PMID: 38419617.

Hauser, RA, A Videnovic, P Soares-da-Silva, GS Liang, K Olson, E Jen, JF Rocha, and O Klepitskaya. 2024. “OFF-Times Before, During, and After Nighttime Sleep Periods in Parkinson’s Disease Patients With Motor Fluctuations and the Effects of Opicapone: A Post Hoc Analysis of Diary Data from BIPARK-1 and -2.”. Parkinsonism Relat Disord. 2024 Jun;123:106971. Doi: 10.1016/J.Parkreldis.2024.106971. Epub 2024 Apr 9.PMID: 38631081.

Martino, D, V Karnik, R Bhidayasiri, DA Hall, RA Hauser, A Macerollo, TM Pringheim, et al. 2023. “Members of the IPMDS Rating Scales Review Committee. Scales for Antipsychotic-Associated Movement Disorders: Systematic Review, Critique, and Recommendations. 2023 Jun;38(6):1008-1026. Doi: 10.1002/Mds.29392. Epub 2023 Apr 20. PMID: 37081740”. Mov Disord.

Hauser, RA, A Favit, LA Hewitt, A Lindsten, S Gomy, S Kymes, and SH Isaacson. 2022. “Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment. Neurol Ther. 2022 Mar;11(1):459-469. Doi: 10.1007/S40120-021-00317-5. Epub 2022 Feb 2. PMID: 35107750.”. Neurol Ther.